Neema Kumari
Overview
Explore the profile of Neema Kumari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ealla K, Durga C, Sahu V, Kumari N, Venkatesan J, Veeraraghavan V, et al.
BMC Oral Health
. 2025 Feb;
25(1):177.
PMID: 39893416
Background: Tooth extraction, a common dental procedure, is often accompanied by pain, trismus, and swelling due to alveolitis caused by oral bacteria. Doxycycline is prescribed to alleviate infection and improve...
2.
Kumari N, Pullaguri N, Rath S, Bajaj A, Sahu V, Ealla K
Cancer Drug Resist
. 2024 Mar;
7:11.
PMID: 38510751
Globally, cancer, as a major public health concern, poses a severe threat to people's well-being. Advanced and specialized therapies can now cure the majority of people with early-stage cancer. However,...
3.
Ealla K, Kumari N, Chintalapani S, Uppu S, Sahu V, Veeraraghavan V, et al.
Arch Microbiol
. 2024 Feb;
206(3):127.
PMID: 38416201
Globally, oral diseases affect nearly 3.5 billion people, accounting for 4.6% of the healthcare expenditure. Common oral diseases include dental caries and periodontal disease, associated with biofilms formed by cariogenic...
4.
Kumar V, Kumari N, Ealla K, Gour S, Srivastava H, Rallabhandi S
Mol Clin Oncol
. 2024 Feb;
20(3):18.
PMID: 38332992
Of note, one third of oral cancer or oral tissue dysfunction cases are from India, primarily resulting from the consumption of Gutkha, a type of smokeless tobacco prevalent among several...
5.
Ealla K, Kumari N, Sahu V, Veeraraghavan V, Peddapalegani P, Ramani P, et al.
Cureus
. 2023 Dec;
15(11):e49554.
PMID: 38156157
Background: Antimicrobial resistance is a pertinent issue in the healthcare sector, accounting for 1.27 million patient deaths worldwide. Dental practitioners account for 3% to 11% of total antibiotic prescriptions. Therefore,...
6.
Kumari N, Pullaguri N, Sahu V, Ealla K
J Biomater Appl
. 2023 Jun;
38(1):39-50.
PMID: 37343291
Despite the availability of advanced treatments, cancer remains the second leading cause of death worldwide. This is due to the many challenges prevailing in the research field and cancer therapy....
7.
Thomas T, Govindharaj M, Unni H, Kumari N, Rath S
Biomed Phys Eng Express
. 2023 May;
9(4).
PMID: 37171088
Droplets of microliter size serve as miniaturized reaction chambers for practical lab on a chip (LoC) applications. The transportation and coalescence of droplets are indispensable for realizing microfluidic mixing. Light...
8.
Kumari N, Giri P, Rath S
Cancer Drug Resist
. 2022 May;
4(4):996-1007.
PMID: 35582374
Chemoresistance is a prevalent issue in cancer treatment. Paclitaxel (PTX) is a microtubule-binding anticancer drug used in various cancer treatments. However, cancer cells often show chemoresistance against PTX with the...
9.
Kumari N, Dalal V, Kumar P, Rath S
J Biomol Struct Dyn
. 2020 Oct;
40(6):2395-2406.
PMID: 33103598
Studies have shown that in cancer cells, there is an increased T-type calcium channel (TTCC) expression compared to healthy cells. Therefore, the studies targeting TTCC for cancer therapy have shown...
10.
Kumari N, Bhargava A, Rath S
Life Sci
. 2020 Aug;
260:118291.
PMID: 32810510
Aims: Despite the advanced cancer treatments, there is increased resistance to chemotherapy and subsequent mortality. In lack of reliable data in monolayer cultures and animal models, researchers are shifting to...